TVARDI THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
TVARDI THERAPEUTICS, INC. (TVRD) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 70.50% for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-05-08
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-03-31 was 70.50%.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-09-30 was 67.72%.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-06-30 was 89.80%.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 89.60%.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 73.79%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2026-03-31 | 70.50% 10-Q · filed 2026-05-08 | |||
| 2025-09-30 | 67.72% 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | 73.79% 10-K · filed 2026-03-31 | |||
| 2024-09-30 | 73.79% 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | 89.80% 10-Q · filed 2024-08-14 | 73.79% 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | 89.60% 10-Q · filed 2025-05-13 | |||
| 2023-09-30 | 80.80% 10-Q · filed 2024-11-14 | |||
| 2019-09-30 | 71.80% 10-Q · filed 2020-11-09 | |||
| 2018-03-31 | 85.90% 10-Q · filed 2019-05-07 | |||
| 2017-06-30 | 83.30% 10-Q · filed 2018-08-07 | |||
| 2016-09-30 | 71.90% 10-Q · filed 2016-11-04 | |||
| 2015-09-30 | 64.10% 10-Q · filed 2016-11-04 | |||
| 2015-06-30 | 64.00% 10-Q · filed 2016-08-04 | |||
| 2014-09-30 | 65.00% 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | 65.00% 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |